<DOC>
	<DOCNO>NCT01106976</DOCNO>
	<brief_summary>The purpose research evaluate change cholinergic brain activity time subject Parkinson disease .</brief_summary>
	<brief_title>Imaging Biomarkers Progression Mobility Impairment Parkinson Disease</brief_title>
	<detailed_description>The project apply positron emission tomography ( PET ) acetylcholinesterase study non-dopaminergic ( i.e . cholinergic ) brain change time subject Parkinson disease . Acetylcholinesterase PET image use assess cholinergic change time study . Acetylcholinesterase PET image diagnostic test investigator assign specific intervention subject study base acetylcholinesterase PET . Therefore , observational study define follow : study human being biomedical and/or health outcome assess pre-defined group individual . Subjects study may receive diagnostic , therapeutic , intervention , investigator assign specific intervention subject study .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients meet UK Parkinson 's Disease Society Brain Bank Research Center clinical diagnostic criterion PD . Hoehn Yahr stag 12.5 initial recruitment baseline study . Absence dementia confirm neuropsychological test initial recruitment baseline study . contraindication magnetic resonance study Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>PET</keyword>
	<keyword>acetylcholine</keyword>
</DOC>